|
GB9708611D0
(en)
*
|
1997-04-28 |
1997-06-18 |
Univ Cardiff |
Chemical compounds
|
|
GB9716231D0
(en)
|
1997-07-31 |
1997-10-08 |
Amersham Int Ltd |
Base analogues
|
|
ATE413881T1
(de)
|
1997-08-08 |
2008-11-15 |
Celmed Oncology Usa Inc |
Verfahren und zubereitungen um resistenz gegen biologische oder chemische therapien zu überwinden
|
|
US7462605B2
(en)
|
1998-01-23 |
2008-12-09 |
Celmed Oncology (Usa), Inc. |
Phosphoramidate compounds and methods of use
|
|
CA2317505C
(en)
|
1998-01-23 |
2011-01-04 |
Newbiotics, Inc. |
Enzyme catalyzed therapeutic agents
|
|
AU774492B2
(en)
|
1999-07-22 |
2004-07-01 |
Celmed Oncology (Usa) Inc. |
Methods for treating therapy-resistant tumors
|
|
US6683061B1
(en)
|
1999-07-22 |
2004-01-27 |
Newbiotics, Inc. |
Enzyme catalyzed therapeutic activation
|
|
GB0009486D0
(en)
*
|
2000-04-17 |
2000-06-07 |
Univ Cardiff |
Chemical compounds
|
|
GB0011203D0
(en)
*
|
2000-05-09 |
2000-06-28 |
Univ Cardiff |
Chemical compounds
|
|
AU2003225701A1
(en)
*
|
2002-03-08 |
2003-09-22 |
Glen Research Corporation |
Fluorescent nitrogenous base and nucleosides incorporating same
|
|
HUE033832T2
(en)
|
2002-11-15 |
2018-01-29 |
Idenix Pharmaceuticals Llc |
2'-methyl nucleosides in combination with interferon and Flaviviridae mutation
|
|
GB0609178D0
(en)
|
2006-05-09 |
2006-06-21 |
Univ Cardiff |
Novel compounds
|
|
US20080261913A1
(en)
|
2006-12-28 |
2008-10-23 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of liver disorders
|
|
EA201270566A1
(ru)
*
|
2009-10-16 |
2012-11-30 |
Риб-Экс Фармасьютикалз, Инк. |
Противомикробные соединения и способы их получения и применения
|
|
NZ599290A
(en)
|
2009-10-16 |
2014-10-31 |
Melinta Therapeutics Inc |
Antimicrobial compounds and methods of making and using the same
|
|
MX2012004341A
(es)
|
2009-10-16 |
2012-10-05 |
Rib X Pharmaceuticals Inc |
Compuestos antimicrobianos y metodos para fabricar y utilizar los mismos.
|
|
GB201016855D0
(en)
*
|
2010-10-06 |
2010-11-17 |
Nucana Biomed Ltd |
Chemical compounds
|
|
EP2691409B1
(en)
|
2011-03-31 |
2018-02-21 |
Idenix Pharmaceuticals LLC. |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
|
MY173518A
(en)
|
2011-04-15 |
2020-01-30 |
Melinta Therapeutics Inc |
Antimicrobial compounds and methods of making and using the same
|
|
GB201111779D0
(en)
|
2011-07-08 |
2011-08-24 |
Univ Cardiff |
Chemical compounds
|
|
TW201329096A
(zh)
|
2011-09-12 |
2013-07-16 |
Idenix Pharmaceuticals Inc |
經取代羰氧基甲基磷酸醯胺化合物及用於治療病毒感染之藥學組成物
|
|
US8507460B2
(en)
|
2011-10-14 |
2013-08-13 |
Idenix Pharmaceuticals, Inc. |
Substituted 3′,5′-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections
|
|
WO2013177188A1
(en)
|
2012-05-22 |
2013-11-28 |
Idenix Pharmaceuticals, Inc. |
3',5'-cyclic phosphoramidate prodrugs for hcv infection
|
|
US9296778B2
(en)
|
2012-05-22 |
2016-03-29 |
Idenix Pharmaceuticals, Inc. |
3′,5′-cyclic phosphate prodrugs for HCV infection
|
|
CA2873315A1
(en)
|
2012-05-22 |
2013-11-28 |
Idenix Pharamaceuticals, Inc. |
D-amino acid compounds for liver disease
|
|
SG11201407336PA
(en)
|
2012-05-25 |
2015-03-30 |
Janssen Sciences Ireland Uc |
Uracyl spirooxetane nucleosides
|
|
WO2014052638A1
(en)
|
2012-09-27 |
2014-04-03 |
Idenix Pharmaceuticals, Inc. |
Esters and malonates of sate prodrugs
|
|
KR102001280B1
(ko)
|
2012-10-08 |
2019-07-17 |
아이데닉스 파마슈티칼스 엘엘씨 |
Hcv 감염에 대한 2'-클로로 뉴클레오시드 유사체
|
|
WO2014066239A1
(en)
|
2012-10-22 |
2014-05-01 |
Idenix Pharmaceuticals, Inc. |
2',4'-bridged nucleosides for hcv infection
|
|
EP2935304A1
(en)
|
2012-12-19 |
2015-10-28 |
IDENIX Pharmaceuticals, Inc. |
4'-fluoro nucleosides for the treatment of hcv
|
|
US9309275B2
(en)
|
2013-03-04 |
2016-04-12 |
Idenix Pharmaceuticals Llc |
3′-deoxy nucleosides for the treatment of HCV
|
|
US9339541B2
(en)
|
2013-03-04 |
2016-05-17 |
Merck Sharp & Dohme Corp. |
Thiophosphate nucleosides for the treatment of HCV
|
|
WO2014160484A1
(en)
|
2013-03-13 |
2014-10-02 |
Idenix Pharmaceuticals, Inc. |
Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of hcv
|
|
EP2981542B1
(en)
|
2013-04-01 |
2021-09-15 |
Idenix Pharmaceuticals LLC |
2',4'-fluoro nucleosides for the treatment of hcv
|
|
US10005779B2
(en)
|
2013-06-05 |
2018-06-26 |
Idenix Pharmaceuticals Llc |
1′,4′-thio nucleosides for the treatment of HCV
|
|
WO2015017713A1
(en)
|
2013-08-01 |
2015-02-05 |
Idenix Pharmaceuticals, Inc. |
D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease
|
|
CA2923214A1
(en)
|
2013-09-09 |
2015-03-12 |
Melinta Therapeutics, Inc. |
Antimicrobial compounds and methods of making and using the same
|
|
EP3038623A4
(en)
|
2013-09-09 |
2017-04-19 |
Melinta Therapeutics, Inc. |
Antimicrobial compounds and methods of making and using the same
|
|
WO2015161137A1
(en)
|
2014-04-16 |
2015-10-22 |
Idenix Pharmaceuticals, Inc. |
3'-substituted methyl or alkynyl nucleosides for the treatment of hcv
|
|
HK1249758A1
(zh)
|
2015-03-11 |
2018-11-09 |
Melinta Therapeutics, Inc. |
抗微生物化合物及其制备和使用方法
|
|
US11098047B2
(en)
|
2016-05-06 |
2021-08-24 |
BioVersys AG |
Antimicrobials and methods of making and using same
|
|
US12606863B2
(en)
|
2021-05-13 |
2026-04-21 |
Promega Corporation |
Bioluminescent detection of DNA synthesis
|
|
US20260062437A1
(en)
*
|
2022-08-26 |
2026-03-05 |
Regents Of The University Of Minnesota |
Antiviral compounds
|